98 related articles for article (PubMed ID: 1539236)
1. Busulphan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia.
Russell S; Vowels M
Transplant Proc; 1992 Feb; 24(1):183. PubMed ID: 1539236
[No Abstract] [Full Text] [Related]
2. Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
Mrsić M; Nemet D; Labar B; Bogdanić V; Radman I; Zupancić-Salek S; Kovacević-Metelko J; Aurer I; Maravić N
Transplant Proc; 1993 Feb; 25(1 Pt 2):1268-70. PubMed ID: 8442109
[No Abstract] [Full Text] [Related]
3. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
[TBL] [Abstract][Full Text] [Related]
4. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
Matsuyama T; Kojima S; Kato K
Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan.
Carpenter PA; Marshall GM; Giri N; Vowels MR; Russell SJ
Bone Marrow Transplant; 1996 Sep; 18(3):489-94. PubMed ID: 8879607
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
8. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients.
Cahn JY; Bordigoni P; Souillet G; Pico JL; Plouvier E; Reiffers J; Benz-Lemoine E; Bergerat JP; Lutz P; Colombat P
Bone Marrow Transplant; 1991 Jan; 7(1):1-4. PubMed ID: 2043871
[TBL] [Abstract][Full Text] [Related]
9. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation.
Geller RB; Myers S; Devine S; Larson RA; Williams SF; Park CL; O'Toole K; Chandler C; Topper RL
Bone Marrow Transplant; 1992 Jan; 9(1):41-7. PubMed ID: 1543948
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation following a busulfan-based conditioning regimen in young children with acute lymphoblastic leukemia: a Cooperative Study of the Société Française de Greffe de Moelle.
von Bueltzingsloewen A; Esperou-Bourdeau H; Souillet G; Demeocq F; Mechinaud-Lacroix F; Michel G; Sadoun A; Bernaudin F; Cornu G; Donadieu J
Bone Marrow Transplant; 1995 Oct; 16(4):521-7. PubMed ID: 8528167
[TBL] [Abstract][Full Text] [Related]
12. Busulfan and cyclophosphamide as conditioning regimen for autologous BMT in acute lymphoblastic leukemia.
Porcellini A; Manna A; Moretti L; Carotenuto M; Greco MM; Bodenizza C
Bone Marrow Transplant; 1989 May; 4(3):331-3. PubMed ID: 2659120
[No Abstract] [Full Text] [Related]
13. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens.
Woods WG; Ramsay NK; Weisdorf DJ; Haake R; Vallera DA; Kim TH; Lasky L; Nesbit ME; Bostrom B; Uckun F
Bone Marrow Transplant; 1990 Jul; 6(1):9-16. PubMed ID: 2202462
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic bone marrow transplantation for ALL in Zagreb.
Bogdanić V; Labar B; Nemet D; Mrsić M; Pavetić Z; Aurer I
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():88-9. PubMed ID: 2697414
[No Abstract] [Full Text] [Related]
15. Bone marrow transplantation for leukemia after conditioning with busulfan and cyclophosphamide. Bone marrow morphology in the early recovery phase.
Cao DC; Tutschka PJ
Chin Med J (Engl); 1991 Apr; 104(4):267-76. PubMed ID: 2065543
[TBL] [Abstract][Full Text] [Related]
16. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
17. Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia.
Wachowiak J; Bettoni C; Lange A; Malicki J; Kaczmarek-Kanold M; Głuszak B; Suchnicki K; Daszkiewicz P; Ebell W
Acta Haematol Pol; 1995; 26(4):377-84. PubMed ID: 8571739
[TBL] [Abstract][Full Text] [Related]
18. TBI, etoposide and cyclophosphamide as a promising conditioning regimen for BMT in childhood ALL in second remission.
Biagi E; Rovelli A; Balduzzi A; De Lorenzo P; Tagliabue A; Uderzo C
Bone Marrow Transplant; 2000 Dec; 26(11):1260-2. PubMed ID: 11149746
[No Abstract] [Full Text] [Related]
19. Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens.
Gassas A; Sung L; Saunders EF; Doyle JJ
Bone Marrow Transplant; 2006 Dec; 38(11):739-43. PubMed ID: 17013424
[TBL] [Abstract][Full Text] [Related]
20. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
Emminger W; Emminger-Schmidmeier W; Haas OA; Urban C; Ambros P; Peters C; Mann G; Fink FM; Ferstl G; Höcker P
Bone Marrow Transplant; 1992 May; 9(5):313-8. PubMed ID: 1617314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]